Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic PhenotypeToomas Jagomäe, Mario Plaas, Kaia Grete Kukker et al.|Cells|2021Cited by 30
Early intervention and lifelong treatment with GLP1 receptor agonist liraglutide in a Wolfram Syndrome rat model with an emphasis on visual neurodegeneration, sensorineural hearing loss and diabetic phenotypeToomas Jagomäe, Mario Plaas, Kadri Seppa et al.|Research Square|2021Cited by 4
Treatment with the dual-incretin agonist DA-CH5 demonstrates potent therapeutic effect in a rat model of Wolfram SyndromeToomas Jagomäe, Mario Plaas, Eero Vasar et al.|Frontiers in Endocrinology|2023Cited by 3